Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab

por Brunner, P.M., Conrad, C., Vender, R., Grond, S., Schuster, C., Patel, H., Xu, W., Carrascosa Carrillo, J.M.
Publicado 2021